Clinical Trial Update: A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase IIb randomized trial of immune checkpoint inhibitor-based maintenance therapy for advanced biliary tract cancer; the study is currently not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Snippet

Sponsor: Yonsei University | Conditions: Biliary Tract Neoplasms, Advanced Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING